IQVIA
IQV
NZ$326.44
Share price
-1.62%
Change (1 day)
-18.79%
Change (1 year)
P/S ratio for IQVIA (IQV)
P/S ratio as of July 2025 (TTM): 2.13
According to IQVIA's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 5.53. At the end of 2025 the company had a P/S ratio of 2.02.
P/S ratio history for IQVIA from 2013 to 2025
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2025 | 2.02 | -14.09% |
| 2024 | 2.35 | -16.64% |
| 2023 | 2.82 | 6.71% |
| 2022 | 2.64 | -32.02% |
| 2021 | 3.88 | 28.46% |
| 2020 | 3.02 | 12.86% |
| 2019 | 2.68 | 21.61% |
| 2018 | 2.20 | 5.6% |
| 2017 | 2.09 | -23.34% |
| 2016 | 2.72 | 90.54% |
| 2015 | 1.43 | 6.74% |
| 2014 | 1.34 | 13.6% |
| 2013 | 1.18 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 NRC Health
NRC | 2.14 | 0.19% | 🇺🇸 USA |
 Nymox Pharmaceutical NYMX | N/A | N/A | Bahamas |